But, while we wait for conclusive evidence, the potential risk remains for people who rely on their pills and who are considering GLP-1 treatments
Can Brazilian patients on SUS (the public health system) access these new semaglutide pens
If I lost access to Ozempic, what I would miss most is that healthy relationship with food, that ability to know that I am full when I'm eating, she said
used for common concerns and to interpret results, build a plan, or prescribe when appropriate
Category-Wise Analysis Drug Type Insights Semaglutide is slated to dominate with approximately 49% of the obesity GLP-1 market revenue share in 2026
Future research can apply our analytic framework to perform a real-world-study-based CEA for either corroborating our findings or translating more real-world comparative effectiveness research to inform clinical professionals and health policymakers when prioritizing treatment strategies for patients with T2D given limited healthcare resources